Trial intelligence / Profile preview

H. pylori Eradication in Parkinson's Disease

NCT02112812Completed

Sponsor
Universiti Kebangsaan Malaysia
Start
Dec 2012
Primary completion
Mar 2013
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of esomeprazole, clarithromycin and amoxicillin in Helicobacter pylori infection, sponsored by Universiti Kebangsaan Malaysia. Primary endpoints: Levodopa onset time at 3 months and Levodopa on-time duration at 3 months. Started Dec 2012; status: completed.

02

Drugs

esomeprazoleclarithromycinamoxicillin
03

Conditions

Helicobacter pylori infection

Beyond the preview

Go deeper on NCT02112812.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02112812.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call